Injured group (n = 54) | Non-injured group (n = 204) | P value | |
---|---|---|---|
All complications (CD ≧ IIIa) | 28 (51.9%) | 113 (55.4%) | 0.642 a |
Recurrent nerve palsy (CD ≧ IIIa) | 4 (7.4%) | 16 (7.8%) | > 0.999 b |
Atelectasis, sputum expectoration disorder (CD ≧ IIIa) | 22 (40.7%) | 80 (39.2%) | 0.838 a |
Pneumonia (CD ≧ IIIa) | 11 (20.4%) | 20 (9.8%) | *0.034 a |
ARDS, respiratory failure (CD ≧ IIIa) | 10 (18.5%) | 16 (7.8%) | *0.020 a |
Pleural effusion (CD ≧ IIIa) | 11 (20.4%) | 51 (25.0%) | 0.479 a |
Chylothorax (CD ≧ IIIa) | 1 (1.9%) | 4 (2.0%) | > 0.999 b |
Anastomotic leakage (CD ≧ IIIa) | 9 (16.7%) | 19 (9.3%) | 0.122 a |
SSI (CD ≧ IIIa) | 10 (18.5%) | 36 (17.6%) | 0.882 a |
ACS, heart failure (CD ≧ IIIa) | 1 (1.9%) | 4 (2.0%) | > 0.999 b |
Tachycardia (Paf, PSVT) (CD ≧ II) | 12 (22.2%) | 53 (26.0) | 0.572 a |
Re-operation (CD ≧ IIIa) | 2 (3.7%) | 15 (7.4%) | 0.538 b |
Mediastinal recurrence | 9 (16.7%) | 18 (8.8%) | 0.094 a |